Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Lyman
Gary H
GH
Effectiveness and Outcomes Research, Duke University, Duke Comprehensive Cancer Center, USA.
D015415:Biomarkers / Q000032:analysis; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006302:Health Services Research / Q000191:economics / Q000592:standards; D006801:Humans; D008495:Medical Oncology / Q000191:economics / Q000592:standards; D008962:Models, Theoretical; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics / Q000378:metabolism / Q000628:therapy*; D018579:Patient Selection; D011159:Population Surveillance; D011237:Predictive Value of Tests; D016032:Randomized Controlled Trials as Topic; D012109:Research Support as Topic; D016896:Treatment Outcome
D015415:Biomarkers